Sanofi
Sanofi, a global healthcare leader headquartered in France, is renowned for its commitment to improving health and well-being. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Operating within the pharmaceutical and biotechnology industry, Sanofi focuses on several main business areas, including prescription medicines, vaccines, and consumer healthcare products. Its core offerings, such as innovative treatments for diabetes, rare diseases, and vaccines, are distinguished by their scientific rigor and patient-centric approach. With a robust market position, Sanofi has achieved notable milestones, including advancements in immunology and oncology, solidifying its reputation as a trusted name in global health solutions.
DitchCarbon Score
How does Sanofi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi's score of 61 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sanofi's reported carbon emissions
In 2025, Sanofi reported total carbon emissions of approximately 634,110,000 kg CO2e, encompassing Scope 1 and 2 emissions. This marks a significant focus on reducing greenhouse gas emissions as part of their broader climate commitments. Sanofi has set ambitious targets to achieve net-zero greenhouse gas emissions across its value chain by FY2045, using FY2019 as the baseline year. In the near term, the company aims to reduce absolute Scope 1 and 2 emissions by 55% by FY2030. Additionally, Sanofi plans to increase its annual sourcing of renewable electricity from 11% in FY2019 to 80% by FY2025 and 100% by FY2030. For Scope 3 emissions, which include those from purchased goods and services, capital goods, and other indirect sources, Sanofi is committed to a 30% reduction by FY2030. Long-term, the company targets a 90% reduction in both Scope 1, 2, and 3 emissions by FY2045. These commitments align with industry standards for climate action, reflecting Sanofi's dedication to sustainability and responsible environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 536,712,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
| Scope 2 | 689,058,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
